Dechra Announces Acquisition of Sucromate™ Equine (deslorelin acetate) sterile suspension from Thorn Bioscience L.L.C.

This acquisition expands Dechra’s equine portfolio in the reproductive category.
Share
Favorite
Please login

No account yet? Register

ADVERTISEMENT

Dechra is pleased to announce the acquisition of Sucromate™ Equine (deslorelin acetate) sterile suspension from Thorn Bioscience L.L.C. This acquisition expands Dechra’s equine portfolio in the reproductive category.

Mike Eldred, President of Dechra North America, stated, “Sucromate Equine is a sterile, synthetic gonadotropin-releasing hormone (GnRH) analog suspension that veterinarians have used and relied on for their breeding operations. Sucromate Equine expands Dechra’s reproductive portfolio and complements our existing product offering.”

Sucromate Equine (deslorelin acetate) sterile suspension should be used exclusively by veterinarians.

The product is now available for veterinarians to purchase through select veterinary distributors.

Share

Written by:

Product and information releases by various organizations and companies.

Related Articles

Stay on top of the most recent Horse Health news with

FREE weekly newsletters from TheHorse.com

Sponsored Content

Weekly Poll

sponsored by:

What signs does your horse show when he has gastric ulcers? Please check all that apply.
87 votes · 216 answers

Readers’ Most Popular

Sign In

Don’t have an account? Register for a FREE account here.

Need to update your account?

You need to be logged in to fill out this form

Create a free account with TheHorse.com!